Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectories.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
21 Aug 2024
Historique:
received: 07 08 2023
accepted: 07 08 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 21 8 2024
Statut: epublish

Résumé

The heterogeneity and complexity of symptom presentation, comorbidities and genetic factors pose challenges to the identification of biological mechanisms underlying complex diseases. Current approaches used to identify biological subtypes of major depressive disorder (MDD) mainly focus on clinical characteristics that cannot be linked to specific biological models. Here, we examined multimorbidities to identify MDD subtypes with distinct genetic and non-genetic factors. We leveraged dynamic Bayesian network approaches to determine a minimal set of multimorbidities relevant to MDD and identified seven clusters of disease-burden trajectories throughout the lifespan among 1.2 million participants from cohorts in the UK, Finland, and Spain. The clusters had clear protective- and risk-factor profiles as well as age-specific clinical courses mainly driven by inflammatory processes, and a comprehensive map of heritability and genetic correlations among these clusters was revealed. Our results can guide the development of personalized treatments for MDD based on the unique genetic, clinical and non-genetic risk-factor profiles of patients.

Identifiants

pubmed: 39168988
doi: 10.1038/s41467-024-51467-7
pii: 10.1038/s41467-024-51467-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7190

Informations de copyright

© 2024. The Author(s).

Références

Fratelli, C., Siqueira, J., Silva, C., Ferreira, E. & Silva, I. 5HTTLPR genetic variant and major depressive disorder: a review. Genes https://doi.org/10.3390/genes11111260 (2020).
Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905–1917 (2006).
pubmed: 17074942
Fried, E. I. & Nesse, R. M. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J. Affect. Disord. 172, 96–102 (2015).
pubmed: 25451401
Flint, J. The genetic basis of major depressive disorder. Mol. Psychiatry; https://doi.org/10.1038/s41380-023-01957-9 (2023).
Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343–352 (2019).
pubmed: 30718901 pmcid: 6522363
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
pubmed: 29700475 pmcid: 5934326
Nguyen, T.-D. et al. Genetic heterogeneity and subtypes of major depression. Mol. Psychiatry 27, 1667–1675 (2022).
pubmed: 34997191 pmcid: 9106834
Dong, G., Feng, J., Sun, F., Chen, J. & Zhao, X.-M. A global overview of genetically interpretable multimorbidities among common diseases in the UK Biobank. Genome Med. 13, 110 (2021).
pubmed: 34225788 pmcid: 8258962
Atun, R. Transitioning health systems for multimorbidity. Lancet 386, 721–722 (2015).
pubmed: 26063473
Langenberg, C., Hingorani, A. D. & Whitty, C. J. M. Biological and functional multimorbidity-from mechanisms to management. Nat. Med. 29, 1649–1657 (2023).
pubmed: 37464031
Aubert, C. E. et al. Patterns of multimorbidity in internal medicine patients in Swiss university hospitals: a multicentre cohort study. Swiss Med. Wkly. 149, w20094 (2019).
pubmed: 31256414
Prasad, B., Bjourson, A. J. & Shukla, P. Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity. Brief. Bioinform. https://doi.org/10.1093/bib/bbac410 (2022).
Kudesia, P. et al. The incidence of multimorbidity and patterns in accumulation of chronic conditions: a systematic review. J. Multimorb. Comorb. 11, 26335565211032880 (2021).
pubmed: 34350127 pmcid: 8287424
Krebs, M. D. et al. Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors. Nat. Commun. 12, 6617 (2021).
pubmed: 34785645 pmcid: 8595374
Marx, P. et al. Comorbidities in the diseasome are more apparent than real: What Bayesian filtering reveals about the comorbidities of depression. PLoS Comput. Biol. 13, e1005487 (2017).
pubmed: 28644851 pmcid: 5507322
González-Colom, R. et al. Multicentric assessment of a multimorbidity adjusted disability score to stratify depression-related risks using temporal disease maps. J. Med. Internet Res. https://doi.org/10.2196/53162 (2023).
Stahl, E. A. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet. 51, 793–803 (2019).
pubmed: 31043756 pmcid: 6956732
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
pmcid: 4112379
Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508–518 (2023).
pubmed: 36653562 pmcid: 9849126
Steinsaltz, D., Dahl, A. & Wachter, K. W. On negative heritability and negative estimates of heritability. Genetics 215, 343–357 (2020).
pubmed: 32291292 pmcid: 7268991
Bradley, T. et al. Systematic review of lifestyle interventions to improve weight, physical activity and diet among people with a mental health condition. Syst. Rev. 11, 198 (2022).
pubmed: 36085250 pmcid: 9462072
Pemberton, R. & Fuller Tyszkiewicz, M. D. Factors contributing to depressive mood states in everyday life: a systematic review. J. Affect. Disord. 200, 103–110 (2016).
pubmed: 27131503
Willadsen, T. G. et al. The effect of disease onset chronology on mortality among patients with multimorbidity: A Danish nationwide register study. J. Multimorb. Comorb. 12, 26335565221122025 (2022).
pubmed: 36032184 pmcid: 9400403
Pan, T. et al. The impact of depression and physical multimorbidity on health-related quality of life in China: a national longitudinal quantile regression study. Sci. Rep. 12, 21620 (2022).
pubmed: 36517510 pmcid: 9750988
Sarris, J. et al. Multiple lifestyle factors and depressed mood: a cross-sectional and longitudinal analysis of the UK Biobank (N = 84,860). BMC Med. 18, 354 (2020).
pubmed: 33176802 pmcid: 7661271
Tylee, D. S. et al. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am. J. Med. Genet. B Neuropsychiatr. Genet. 177, 641–657 (2018).
pubmed: 30325587 pmcid: 6230304
Gupta, J. et al. Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry. J. Allergy Clin. Immunol. 138, 676–699 (2016).
pubmed: 27297995 pmcid: 5014679
Cao, H., Li, S., Baranova, A. & Zhang, F. Shared genetic liability between major depressive disorder and atopic diseases. Front. Immunol. 12, 665160 (2021).
pubmed: 34566951 pmcid: 8455950
Fang, Y., Fritsche, L. G., Mukherjee, B., Sen, S. & Richmond-Rakerd, L. S. Polygenic liability to depression is associated with multiple medical conditions in the electronic health record: phenome-wide association study of 46,782 individuals. Biol. Psychiatry 92, 923–931 (2022).
pubmed: 35965108 pmcid: 10712651
Tylee, D. S. et al. An atlas of genetic correlations and genetically informed associations linking psychiatric and immune-related phenotypes. JAMA Psychiatry 79, 667–676 (2022).
pubmed: 35507366 pmcid: 9069342
Schoepf, D., Uppal, H., Potluri, R., Chandran, S. & Heun, R. Comorbidity and its relevance on general hospital based mortality in major depressive disorder: a naturalistic 12-year follow-up in general hospital admissions. J. Psychiatr. Res. 52, 28–35 (2014).
pubmed: 24513499
Harsanyi, S., Kupcova, I., Danisovic, L. & Klein, M. Selected biomarkers of depression: what are the effects of cytokines and inflammation? Int. J. Mol. Sci. https://doi.org/10.3390/ijms24010578 (2022).
Berk, M. et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 11, 200 (2013).
pubmed: 24228900 pmcid: 3846682
Tamouza, R., Krishnamoorthy, R. & Leboyer, M. Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain Behav. Immun. 91, 731–739 (2021).
pubmed: 33031918
Glanville, K. P. et al. Classical human leukocyte antigen alleles and C4 haplotypes are not significantly associated with depression. Biol. Psychiatry 87, 419–430 (2020).
pubmed: 31570195 pmcid: 7001040
Howard, D. M. et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat. Commun. 9, 1470 (2018).
pubmed: 29662059 pmcid: 5902628
Bonk, S. et al. Impact of gene-by-trauma interaction in MDD-related multimorbidity clusters. J. Affect. Disord. 359, 382–391 (2024).
pubmed: 38806065
Chan, K. L., Cathomas, F. & Russo, S. J. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology 34, 123–133 (2019).
pubmed: 30724127 pmcid: 6586832
Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22–34 (2016).
pubmed: 26711676 pmcid: 5542678
Toenders, Y. J. et al. Inflammation and depression in young people: a systematic review and proposed inflammatory pathways. Mol. Psychiatry 27, 315–327 (2022).
pubmed: 34635789
Smith, D. J. et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK biobank: cross-sectional study of 172,751 participants. PLoS ONE 8, e75362 (2013).
pubmed: 24282498 pmcid: 3839907
Nagel, M., Watanabe, K., Stringer, S., Posthuma, D. & van der Sluis, S. Item-level analyses reveal genetic heterogeneity in neuroticism. Nat. Commun. 9, 905 (2018).
pubmed: 29500382 pmcid: 5834468
Eszlari, N. et al. Biology of perseverative negative thinking: the role of timing and folate intake. Nutrients https://doi.org/10.3390/nu13124396 (2021).
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975
Eszlari, N. et al. Genome-wide association analysis reveals KCTD12 and miR-383-binding genes in the background of rumination. Transl. Psychiatry 9, 119 (2019).
pubmed: 30886212 pmcid: 6423133
Farré, N. et al. Medical resource use and expenditure in patients with chronic heart failure: a population-based analysis of 88 195 patients. Eur. J. Heart Fail. 18, 1132–1140 (2016).
pubmed: 27108481
Sund, R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand. J. Public Health 40, 505–515 (2012).
pubmed: 22899561
Borodulin, K. et al. Cohort profile: The National FINRISK Study. Int. J. Epidemiol. 47, 696–696i (2018).
pubmed: 29165699
Heistaro, S. Methodology Report. Health 2000 Survey (National Public Health Institute, Helsinki, 2008).
Völzke, H. et al. Cohort profile update: The Study of Health in Pomerania (SHIP). Int. J. Epidemiol. 51, e372–e383 (2022).
pubmed: 35348705
Schulz, A. et al. The impact of childhood trauma on depression: does resilience matter? Population-based results from the Study of Health in Pomerania. J. Psychosom. Res. 77, 97–103 (2014).
pubmed: 25077849
Gamerman, D. & Lopes, H. F. Markov Chain Monte Carlo (Chapman and Hall/CRC, 2006).
Antal, P. et al. Bayesian, systems-based, multilevel analysis of associations for complex phenotypes: from interpretation to decision. In Probabilistic Graphical Models for Genetics, Genomics, and Postgenomics (eds Sinoquet, C. & Mourad, R.) 318–360 (Oxford Univ. Press, Oxford, 2014).
R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2022).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. GigaScience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193
Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097–1103 (2021).
pubmed: 34017140
Watanabe, K., Umićević Mirkov, M., de Leeuw, C. A., van den Heuvel, M. P. & Posthuma, D. Genetic mapping of cell type specificity for complex traits. Nat. Commun. 10, 3222 (2019).
pubmed: 31324783 pmcid: 6642112
Leeuw, C. A., de, Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657
Korotkevich G., Sukhov V., Sergushichev A. Fast gene set enrichment analysis. Preprint at bioRxiv http://biorxiv.org/content/early/2016/06/20/060012 (2019).
Raudvere, U. et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191–W198 (2019).
pubmed: 31066453 pmcid: 6602461
Cuellar-Partida, G. et al. Complex-traits genetics virtual lab: a community-driven web platform for post-GWAS analyses. Preprint at bioRxiv https://doi.org/10.1101/518027 (2019).
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769
Ge, T., Chen, C.-Y., Ni, Y., Feng, Y.-C. A. & Smoller, J. W. Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat. Commun. 10, 1776 (2019).
pubmed: 30992449 pmcid: 6467998
Satopaa, V., Albrecht, J., Irwin, D. & Raghavan, B. Finding a “Kneedle” in a haystack: detecting knee points in system behavior. In 2011 31st International Conference on Distributed Computing Systems Workshops 166–171 (IEEE, 2011).
Leiserson, M. D. M. et al. Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat. Genet. 47, 106–114 (2015).
pubmed: 25501392
Troyanskaya, O. et al. Missing value estimation methods for DNA microarrays. Bioinformatics 17, 520–525 (2001).
pubmed: 11395428
Gezsi, A., et al. Unique genetic and risk-factor profiles in clusters of major depressive disorder-related multimorbidity trajectories. Zenodo https://doi.org/10.5281/zenodo.12744319 , https://github.com/gezsi/mdd-clustering (2024).
Pasman, J. A. et al. Epidemiological overview of major depressive disorder in Scandinavia using nationwide registers. Lancet Reg. Health Eur. 29, 100621 (2023).
pubmed: 37265784 pmcid: 10230616
Berk, M. et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry 22, 366–387 (2023).
pubmed: 37713568 pmcid: 10503929
Merikangas, K. R. & Kalaydjian, A. Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys. Curr. Opin. Psychiatry 20, 353–358 (2007).
pubmed: 17551350
Moussavi, S. et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851–858 (2007).
pubmed: 17826170
Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. Science https://doi.org/10.1126/science.aap8757 (2018).
Wang, K., Gaitsch, H., Poon, H., Cox, N. J. & Rzhetsky, A. Classification of common human diseases derived from shared genetic and environmental determinants. Nat. Genet. 49, 1319–1325 (2017).
pubmed: 28783162 pmcid: 5577363
Menche, J. et al. Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347, 1257601 (2015).
pubmed: 25700523 pmcid: 4435741
Barabási, A.-L., Gulbahce, N. & Loscalzo, J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56–68 (2011).
pubmed: 21164525 pmcid: 3140052
Rzhetsky, A., Wajngurt, D., Park, N. & Zheng, T. Probing genetic overlap among complex human phenotypes. Proc. Natl. Acad. Sci. USA 104, 11694–11699 (2007).
pubmed: 17609372 pmcid: 1906727
Jia, G. et al. Discerning asthma endotypes through comorbidity mapping. Nat. Commun. 13, 6712 (2022).
pubmed: 36344522 pmcid: 9640644

Auteurs

Andras Gezsi (A)

Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.

Sandra Van der Auwera (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Centre for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.

Hannu Mäkinen (H)

Department of Public Health and Welfare, Population Health Unit, Public Health Research Team, Finnish Institute for Health and Welfare, Helsinki, Finland.

Nora Eszlari (N)

Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.

Gabor Hullam (G)

Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.

Tamas Nagy (T)

Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.
Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.

Sarah Bonk (S)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Rubèn González-Colom (R)

Clínic Barcelona, Fundació de Recerca Clinic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Xenia Gonda (X)

Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.

Linda Garvert (L)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Teemu Paajanen (T)

Department of Public Health and Welfare, Population Health Unit, Public Health Research Team, Finnish Institute for Health and Welfare, Helsinki, Finland.

Zsofia Gal (Z)

Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary.
NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary.

Kevin Kirchner (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Andras Millinghoffer (A)

Abiomics Europe Ltd., Budapest, Hungary.

Carsten O Schmidt (CO)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Bence Bolgar (B)

Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.

Josep Roca (J)

Clínic Barcelona, Fundació de Recerca Clinic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Isaac Cano (I)

Clínic Barcelona, Fundació de Recerca Clinic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Universitat de Barcelona, Barcelona, Spain.

Mikko Kuokkanen (M)

Department of Public Health and Welfare, Population Health Unit, Public Health Research Team, Finnish Institute for Health and Welfare, Helsinki, Finland.
Department of Human Genetics and South Texas Diabetes and Obesity Institute, School of Medicine at University of Texas Rio Grande Valley, Brownsville, TX, USA.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Peter Antal (P)

Department of Artificial Intelligence and Systems Engineering, Budapest University of Technology and Economics, Budapest, Hungary.

Gabriella Juhasz (G)

Department of Pharmacodynamics, Faculty of Pharmaceutical Sciences, Semmelweis University, Budapest, Hungary. juhasz.gabriella@semmelweis.hu.
NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary. juhasz.gabriella@semmelweis.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH